|
|
|
|
| Advertisement |
 |
|
|
| Top Story |
|
|
Pharma’s Big Push for Value |
Terry Hisey and Brett J. Davis offer a “how to” primer for life sciences companies on applying end-to-end evidence strategies in demonstrating product value
... /Read more/ |
|
|
| Advertisement |
Watch this brief video to hear how trusted case managers can drive patient adherence and better outcomes using in-home education and tele-health support.
 Learn more |
| Advertisement |
6 STEPS TO ENSURE SUCCESSFUL PATIENT ACCESS TO INNOVATIVE THERAPIES
LIVE WEBCAST: Thursday, May 26, 2016 at 4 pm BST | 5 pm CEST
 Free registration |
| Advertisement |
Understanding the Chronic Disease Patient Journey in Emerging Markets
LIVE WEBCAST: Thursday, May 12, 2016, 11 am EDT / 4 pm BST /
5 pm CEST
Register now and join market research consultants Marc Yates and Rachel Howard for this complimentary webinar in which they will explore the chronic disease patient journey in emerging markets. Utilising local knowledge and detailed case studies, they will examine the patient journey from origination through to presentation, diagnosis, treatment choice, follow up and compliance and outline both the opportunities and challenges for global pharma at each stage.
 Free registration |
|
| Patients |
|
|
Fighting Cancer, John Wayne Style
|
How John Wayne viewed his battles with cancer was consistent with the heroic, tough-guy persona he projected onscreen. He’s still inspiring patients today, writes Julian Upton
... /Read more/ |
|
|
| Advertisement |
Medical science liaisons Optimizing their impact during product launch
On Demand
 Learn more |
|
|
| Industry update |
| //Contract medical research provider Quintiles and healthcare information company IMS Health announced they are to merge in a deal that will give the new combined company a market value of around $18 billion.//Astellas (Northbrook, IL) announced the appointment of Rodrigo Fernandez to Executive Director, International Business with responsibility for managing Astellas' business in Latin America outside of Brazil.//Following the appointment of Joseph C. Papa as Valeant's Chairman, Valeant (Laval, Quebec, Canada) has reported that five current independent directors have been nominated for re-election to the Board: William A. Ackman, Dr. Frederic Eshelman, Stephen Fraidin, D. Robert Hale and Thomas W. Ross, Sr. Not standing for re-election are Ronald H. Farmer, Colleen Goggins, Theo Melas-Kyriazi, G. Mason Morfit and Norma A. Provencio.// |
| Advertisement |
Precision asset valuation Leveraging insights from clinical and market access big data
Live webinar: Wednesday, May 11, 2016 at 11:00 am EDT • 4:00 pm BST • 5:00 pm CEST
If you are looking to maximize the value of your portfolio, there are multiple variables that can influence the success of assets in development. Considering the impact of time, cost, probability of success, and HTA can provide more precise and robust expectations. Understand how to incorporate market access into valuations and what strategies optimize your asset's value.
 Register here>> |
|
|
|
| |
|
|
